Together we shape the future of HPB

Overcoming the threat​ of infection outbreaks:​ A necessity​

Helping ensure the safety of your team and your patients alike

infection prevention

Infection outbreaks within the ERCP pathway can compromise patient outcomes and place an additional burden on hospitals.¹

​As antimicrobial resistance and viral pandemics pose an increasing threat to the ability of health systems to maintain services and achieve optimal patient outcomes,² it becomes ever more important to eliminate preventable infection outbreaks.​

SpyGlass clinical SpyBite

While the risk of ERCP-related infections is considered low, they can be severe, multidrug-resistant, and life threatening, highlighting the importance of infection prevention in this clinical setting.1,3,4

​Up to 1% of duodenoscope-related infections were associated with carbapenem-resistant Enterobacteriaceae (CRE).⁵

In the case of multidrug-resistant infections, the associated mortality rate can be as high as 70%.⁶

Facilitating infection prevention in the HPB (hepato-pancreato-biliary) pathway

At Boston Scientific, we understand the array of obstacles you face in ensuring that your patients undergoing ERCP avoid infection. That is why we have developed solutions for every step in the process.​

Before a procedure​

Before a procedure

Facilitate infection prevention and protect patients with risk assessments and single-use, sterile solutions.​

Before a procedure
SpyGlass clinical SpyBite

During a procedure

Eliminate the risk of contaminated equipment with our single-use materials, optimized for infection prevention.​

During a procedure​
Reprocessing materials

After a procedure​

Avoid resource-intensive, complex and time-sensitive reprocessing with our portfolio of disposable products.

After a procedure​

Connect with us:

representing downloading a document or information

Product catalogue​

Download the product catalogue
representing email correspondence

Get updates

Get updates​

References

1. Wendorf KA, Kay M, Baliga C, et al. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol. 2015;36(6):634-642.​

2. Knight GM, Glover RE, McQuaid CF, et al. Antimicrobial resistance and COVID-19: intersections and implications. Elife. 2021;10:e64139.​

​3. Epstein L, Hunter JC, Arwady MA, et al. New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014;312(14):1447-1455.​

4. Kim S, Russell D, Mohamadnejad M, et al. Risk factors associated with the transmission of carbapenem-resistant Enterobacteriaceae via contaminated duodenoscopes. Gastrointest Endosc. 2016;83(6):1121-1129.​

5. Bang JY, Sutton B, Hawes R, Varadarajulu S. Concept of disposable duodenoscope: at what cost? Gut. 2019;68(11):1915-1917.​

​6. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. ISBN 978-9 2-4-155017-8 © World Health Organization 2017.​

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.​​All images owned by Boston Scientific.​